Impaired Cerebral Autoregulation and Vasomotor Reactivity in Sporadic Alzheimer's Disease

Current Alzheimer Research

Volumn 11, Issue 1, 2014, Pages 11-17

  Meel van den Abeelen, Aisha S S ^a   Lagro, Joep ^a   van Beek, Arenda H E A ^a   Claassen, Jurgen A H R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Cerebral amyloid angiopathy; Cerebral circulation; Transcranial doppler

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN VASCULAR RESISTANCE; BREATHING; CARBON DIOXIDE BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSED BLOOD PRESSURE; DOPPLER ECHOGRAPHY; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPERVENTILATION; HYPOCAPNIA; IMPAIRED CEREBRAL AUTOREGULATION; INHALATION; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; TRANSCRANIAL DOPPLER; VASCULAR AMYLOIDOSIS; VASOMOTOR REFLEX;

AGED; ALZHEIMER DISEASE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; FEMALE; HOMEOSTASIS; HUMANS; HYPERCAPNIA; MALE; MOVEMENT; POSTURE; VASOMOTOR SYSTEM;

EID: 84891749685     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205010666131119234845     Document Type: Article

References (32)

1. Burns A. The burden of Alzheimer's disease. Int J Neuropsychopharmacol 3(7): 31-8 (2000).
2. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7(9): 812-26 (2008)
3. Newman AB, Fitzpatrick AL, Lopez O, Jackson S, Lyketsos C, Jagust W, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53(7):1101-7 (2005).
4. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. JAMA 277(10): 813-7 (1997).
5. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, et al. Cerebrovascular pathology and dementia in autopsied Honolulu- Asia Aging Study participants. Ann NY Acad Sci 977: 9-23 (2002).
6. Iwamoto T, Kanetaka H, Takasak M, Takazawa K. Hemodynamic changes in Alzheimer's and Binswanger's diseases as evaluated by second-derivative finger photoplethysmography. Geriatr Gerontol Int 3: 243-9 (2003).
7. Panerai RB. Assessment of cerebral pressure autoregulation in humans--a review of measurement methods. Physiol Meas 19(3): 305-38 (1998).
8. van Beek AH, Claassen JA, Rikkert MG, Jansen RW. Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28(6): 1071-85 (2008).
9. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283(1): H315-23 (2002).
10. Dorr A, Sahota B, Chinta LV, Brown ME, Lai AY, Ma K, et al. Amyloid-beta-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. Brain 135(Pt 10): 3039-50 (2012).
11. Claassen JA, Zhang R. Cerebral autoregulation in Alzheimer's disease. J Cereb Blood Flow Metab 31(7): 1572-7 (2011).
12. Kety SS, Schmidt CF. The Effects of Altered Arterial Tensions of Carbon Dioxide and Oxygen on Cerebral Blood Flow and Cerebral Oxygen Consumption of Normal Young Men. J Clin Invest 27(4): 484-92 (1948).
13. Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht- Talboo J, et al. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gammasecretase inhibition. J Neurosci 28(50): 13542-50 (2008).
14. Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 51(12): 1198-204 (1994).
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-44 (1984).
16. Meulenbroek O, Vernooij-Dassen M, Kessels R, Graff M, Sjogren M, Schalk B, et al. Informed consent in demetnia research. Legislation, theoretical concepts and how to assess capacity to consent. Eur Geriatr Med 1(1): 58-63 (2010).
17. Imholz BP, Wieling W, Langewouters GJ, van Montfrans GA. Continuous finger arterial pressure: utility in the cardiovascular laboratory. Clin Auton Res 1991; 1(1): 43-53 (1999).
18. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurol Surg 57(6): 769-74 (1982).
19. van Beek AH, Olde Rikkert MG, Pasman JW, Hopman MT, Claassen JA. Dynamic cerebral autoregulation in the old using a repeated sit-stand maneuver. Ultrasound Med Biol 36(2): 192-201 (2010).
20. van Beek AH, de Wit HM, Olde Rikkert MG, Claassen JA. Incorrect performance of the breath hold method in the old underestimates cerebrovascular reactivity and goes unnoticed without concomitant blood pressure and end-tidal CO(2) registration. J Neuroimaging 21(4): 340-7 (2011).
21. Claassen JA, Zhang R, Fu Q, Witkowski S, Levine BD. Transcranial Doppler estimation of cerebral blood flow and cerebrovascular conductance during modified rebreathing. J Appl Physiol 102(3): 870-7 (2007).
22. Bar KJ, Boettger MK, Seidler N, Mentzel HJ, Terborg C, Sauer H. Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy. Stroke 38(12): 3186-92 (2007).
23. Claassen JA, Diaz-Arrastia R, Martin-Cook K, Levine BD, Zhang R. Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J Alzheimers Dis 17(3): 621-9 (2009).
24. Gommer ED, Martens EG, Aalten P, Shijaku E, Verhey FR, Mess WH, et al. Dynamic cerebral autoregulation in subjects with Alzheimer's disease, mild cognitive impairment, and controls: evidence for increased peripheral vascular resistance with possible predictive value. J Alzheimers Dis 30(4): 805-13 (2012).
25. Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat Med 16(12): 1370-1 (2010).
26. Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One 7(5): e36893 (2012).
27. van Beek AH, Lagro J, Olde-Rikkert MG, Zhang R, Claassen JA. Oscillations in cerebral blood flow and cortical oxygenation in Alzheimer's disease. Neurobiol Aging 33(2): 428 e21-31 (2012).
28. van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA. Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesteraseinhibitor use. J Alzheimers Dis 21(2): 519-26 (2012).
29. Zazulia AR, Videen TO, Morris JC, Powers WJ. Autoregulation of cerebral blood flow to changes in arterial pressure in mild Alzheimer's disease. J Cereb Blood Flow Metab 30(11): 1883-9 (2010).
30. Menendez-Gonzalez M, Garcia-Garcia J, Calleja S, Rojo J, Ribacoba R. Vasomotor Reactivity Is Similarly Impaired in Patients with Alzheimer's Disease and Patients with Amyloid Hemorrhage. J Neuroimag 21(2): e83-e5 (2011).
31. Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, et al. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology 59(7): 1022-8 (2002).
32. Spies P, Verbeek M, Sjörgen M, de Leeuw F, Claassen J. Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population. Curr Alzheimer Res 11(1): 40-47(2013).